Investigating the effects of Pentoxifylline on human breast cancer cells using Raman spectroscopy

Peeyush N. Goel; S. P. Singh; C. Murali Krishna; R. P. Gude

doi:10.1142/s1793545815500042

[1] G. Tarafa, D. Tuck, D. Ladner, M. Topazian, R. Brand, C. Deters, V. Moreno, G. Capella, H. Lynch, P. Lizardi, J. Costa, "Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis," Proc. Natl. Acad. Sci. USA 105, 4306–4311 (2008).

[2] J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, D. M. Parkin, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008," Int. J. Cancer 127, 2893–2917 (2010).

[3] A. Mullard, "Could pharma open its drug freezersff," Nat. Rev. Drug. Discov. 10(6), 399–400 (2011).

[4] M. Zhang, Y. J. Xu, S. A. Mengi, A. S. Arneja, N. S. Dhalla, "Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases," Exp. Clin. Cardiol. 9(2), 103–111 (2004).

[5] L. Hirsh, A. Dantes, B. S. Suh, Y. Yoshida, K. Hosokawa, K. Tajima, F. Kotsuji, O. Merimsky, A. Amsterdam, "Phosphodiesterase inhibitors as anti-cancer drugs," Biochem. Pharmacol. 68(6), 981–988 (2004).

[6] P. N. Goel, R. P. Gude, "Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells," Mol. Cell. Biochem. 358(1–2), 141–151 (2011).

[7] G. Biolo, B. Ciocchi, A. Bosutti, R. Situlin, G. Toigo, G. Guarnieri, "Pentoxifylline acutely reduces protein catabolism in chronically uremic patients," Am. J. Kidney Dis. 40(6), 1162–1172 (2002).

[8] M. K. Chae, S. G. Park, S.-O. Song, E. S. Kang, B. S. Cha, H. C. Lee, B.-W. Lee, "Pentoxifylline attenuates Methionine- and Choline-deficient-dietinduced steatohepatitis by suppressing TNF-α expression and endoplasmic reticulum stress," Exp. Diabetes Res. 2012, 1–8 (2012).

[9] C. O. Zein, R. Lopez, X. Fu, J. P. Kirwan, L. M. Yerian, A. J. McCullough, S. L. Hazen, A. E. Feldstein, "Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism," Hepatology 56(4), 1291–1299 (2012).

[10] Y. Sato, T. Miura, Y. Suzuki, "Interaction of pentoxifylline with human erythrocytes. III. Comparison of fluidity change of erythrocyte membrane caused by S-adenosyl-L-methionine with that by pentoxifylline," Chem. Pharm. Bull. (Tokyo) 39(2), 468–473 (1991).

[11] A. Amirkhosravi, G. Warnes, J. Biggersta , Z. Malik, K. May, J. L. Francis, "The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse Neuro2a neuroblastoma," Clin. Exp. Metastasis 15(4), 453–461 (1997).

[12] L. Bohm, "Inhibition of homologous recombination repair with Pentoxifylline targets G2 cells generated by radiotherapy and induces major enhancements of the toxicity of cisplatin and melphalan given after irradiation," Radiat. Oncol. 1(1), 12 (2006).

[13] S. S. B. R. Ambrus Jl, "EFfect of pentoxifylline on carbohydrate metabolism in type ii diabetics," Arch. Intern. Med. 150(4), 921–921 (1990).

[14] D. Lin, J. Lin, Y. Wu, S. Feng, Y. Li, Y. Yu, G. Xi, H. Zeng, R. Chen, "Investigation on the interactions of lymphoma cells with paclitaxel by Raman spectroscopy," Spectroscopy 25(1), 23–32 (2011).

[15] E. V. Efremov, F. Ariese, C. Gooijer, "Achievements in resonance Raman spectroscopy review of a technique with a distinct analytical chemistry potential," Anal.Chim.Acta. 606(2), 119–134 (2008).

[16] A. Nijssen, S. Koljenovic, T. C. Bakker Schut, P. J. Caspers, G. J. Puppels, "Towards oncological application of Raman spectroscopy," J. Biophotonics 2(1–2), 29–36 (2009).

[17] E. B. Hanlon, R. Manoharan, T. W. Koo, K. E. Shafer, J. T. Motz, M. Fitzmaurice, J. R. Kramer, I. Itzkan, R. R. Dasari, M. S. Feld, "Prospects for in vivo Raman spectroscopy," Phys. Med. Biol. 45(2), R1–59 (2000).

[18] A. Mahadevan-Jansen, R. R. Richards-Kortum, "Raman spectroscopy for the detection of cancers and precancers," J. Biomed. Opt. 1(1), 31–70 (1996).

[19] J. R. Baena, B. Lendl, "Raman spectroscopy in chemical bioanalysis," Curr. Opin. Chem. Biol. 8 (5), 534–539 (2004).

[20] D. Naumann, "FT-Infrared and FT-Raman spectroscopy in biomedical research," App. Spectrosc. Rev. 236(2–3), 239–298 (2001)

[21] K. W. Short, S. Carpenter, J. P. Freyer, J. R. Mourant, "Raman spectroscopy detects biochemical changes due to proliferation in mammalian cell cultures," Biophys. J. 88(6), 4274–4288 (2005).

[22] C. M. Krishna, G. Kegelaer, I. Adt, S. Rubin, V. B. Kartha, M. Manfait, G. D. Sockalingum, "Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines," Biopolymers 82(5), 462–470 (2006).

[23] R. J. Swain, G. Jell, M. M. Stevens, "Non-invasive analysis of cell cycle dynamics in single living cells with Raman micro-spectroscopy," J. Cell. Biochem. 104(4), 1427–1438 (2008).

[24] M. V. Chowdary, K. K. Kumar, J. Kurien, S. Mathew and C. M. Krishna, "Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy," Biopolymers 83(5), 556–569 (2006).

[25] R. Malini, K. Venkatakrishna, J. Kurien, K. M. Pai, L. Rao, V. B. Kartha, C. M. Krishna, "Discrimination of normal, inflammatory, premalignant, and malignant oral tissue: A Raman spectroscopy study," Biopolymers 81(3), 179–193 (2006).

[26] J. Guo, W. Cai, B. Du, M. Qian, Z. Sun, "Raman spectroscopic investigation on the interaction of malignant hepatocytes with doxorubicin," Biophys. Chem. 140(1–3), 57–61 (2009).

[27] W. Xie, Y. Ye, A. Shen, L. Zhou, Z. Lou, X. Wang, J. Hu, "Evaluation of DNA-targeted anti-cancer drugs by Raman spectroscopy," Vib. Spectrosc. 47(2), 119–123 (2008).

[28] S. Akyuz, A. E. Ozel, K. Balci, T. Akyuz, A. Coker, E. D. Arisan, N. Palavan-Unsal, A. Ozalpan, "Raman micro-spectroscopic analysis of cultured HCT116 colon cancer cells in the presence of roscovitine," Spectrochim. Acta A Mol. Biomol. Spectrosc. 78(5), 1540–1547 (2011).

[29] K. Brautigam, T. Bocklitz, M. Schmitt, P. Rosch, J. Popp, "Raman spectroscopic imaging for the realtime detection of chemical changes associated with docetaxel exposure," Chemphyschem 14(3), 550– 553 (2013).

[30] R. N. Aravalli, J. Choi, S. Mori, D. Mehra, J. Dong, J. C. Bischof, E. N. Cressman, "Spectroscopic and calorimetric evaluation of chemically induced protein denaturation in HuH-7 liver cancer cells and impact on cell survival," Technol. Cancer Res. Treat. 11(5), 467–473 (2012).

[31] K. Hartmann, M. Becker-Putsche, T. Bocklitz, K. Pachmann, A. Niendorf, P. Rosch, J. Popp, "A study of Docetaxel-induced effects in MCF-7 cells by means of Raman microspectroscopy," Anal. Bioanal. Chem. 403(3), 745–753 (2012).

[32] K. le Roux, L. C. Prinsloo, A. A. Hussein, N. Lall, "A micro-Raman spectroscopic investigation of leukemic U-937 cells treated with Crotalaria agatiflora Schweinf and the isolated compound madurensine," Spectrochim. Acta A Mol. Biomol. Spectrosc. 95, 547–554 (2012).

[33] C. Murali Krishna, G. Kegelaer, I. Adt, S. Rubin, V. B. Kartha, M. Manfait, G. D. Sockalingum, "Characterisation of uterine sarcoma cell lines exhibiting MDR phenotype by vibrational spectroscopy," Biochim. Biophys. Acta 1726(2), 160–167 (2005).

[34] C. M. Krishna, G. D. Sockalingum, G. Kegelaer, S. Rubin, V. B. Kartha, M. Manfait, "Micro-Raman spectroscopy of mixed cancer cell populations," Vib. Spectrosc. 38(1), 95–100 (2005).

[35] A. Nijssen, K. Maquelin, L. F. Santos, P. J. Caspers, T. C. Bakker Schut, J. C. den Hollander, M. H. Neumann, G. J. Puppels, "Discriminating basal cell carcinoma from perilesional skin using high wavenumber Raman spectroscopy," J. Biomed. Opt. 12 (3), 034004 (2007).

[36] S. P. Singh, A. Sahu, A. Deshmukh, P. Chaturvedi, C. M. Krishna, "In vivo Raman spectroscopy of oral buccal mucosa: A study on malignancy associated changes (MAC)/cancer field effects (CFE)," Analyst 138(14), 4175–4182 (2013).

[37] A. D. Ghanate, S. Kothiwale, S. P. Singh, D. Bertrand, C. M. Krishna, "Comparative evaluation of spectroscopic models using different multivariate statistical tools in a multicancer scenario," J. Biomed. Opt. 16(2), 025003 (2011).

[38] A. Bravo-Cuellar, P. C. Ortiz-Lazareno, J.M. Lerma- Diaz, J. R. Dominguez-Rodriguez, L. F. Jave-Suarez, A. Aguilar-Lemarroy, S. del Toro-Arreola, R. de Celis- Carrillo, J. E. Sahagun-Flores, J. E. de Alba-Garcia, G. Hernandez-Flores, "Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence," Mol. Cancer 9, 114–127 (2010).

[39] A. J. Shaywitz, M. E. Greenberg, "CREB: A stimulus- induced transcription factor activated by a diverse array of extracellular signals," Annu. Rev. Biochem. 68 821–861 (1999).

[40] G. J. Puppels, F. F. M. de Mul, C. Otto, J. Greve, M. Robert-Nicoud, D. J. Arndt-Jovin, T. M. Jovin, "Studying single living cells and chromosomes by confocal Raman microspectroscopy," Nature 347 (6290), 301–303 (1990).

[41] G. J. Puppels, H. S. Garritsen, G. M. Segers-Nolten, F. F. de Mul, J. Greve, "Raman microspectroscopic approach to the study of human granulocytes," Biophys. J. 60(5), 1046–1056 (1991).

[42] G. J. Puppels, J. H. F. Olminkhof, G. M. J. Segers- Nolten, C. Otto, F. F. M. de Mul, J. Greve, "Laser irradiation and Raman spectroscopy of single living cells and chromosomes: Sample degradation occurs with 514.5 nm but not with 660 nm laser light," Exp. Cell Res. 195(2), 361–367 (1991).

[43] F. Bonnier, S. M. Ali, P. Knief, H. Lambkin, K. Flynn, V. McDonagh, C. Healy, T. C. Lee, F. M. Lyng, H. J. Byrne, "Analysis of human skin tissue by Raman microspectroscopy: Dealing with the background," Vib. Spectrosc. 61(0), 124–132 (2012).

[44] S. R. Hawi, W. B. Campbell, A. Kajdacsy-Balla, R. Murphy, F. Adar, K. Nithipatikom, "Characterization of normal and malignant human hepatocytes by Raman microspectroscopy," Cancer Lett. 110(1–2), 35–40 (1996).

[45] W. T. Cheng, M. T. Liu, H. N. Liu, S. Y. Lin, "Micro-Raman spectroscopy used to identify and grade human skin pilomatrixoma," Microsc. Res. Tech. 68(2), 75–79 (2005).

[46] Z. Movasaghi, S. Rehman, I. U. Rehman, "Raman spectroscopy of biological tissues," App. Spectrosc. Rev. 42(5), 493–541 (2007).

[47] I. Notingher, C. Green, C. Dyer, E. Perkins, N. Hopkins, C. Lindsay, L. L. Hench, "Discrimination between ricin and sulphur mustard toxicity in vitro using Raman spectroscopy," J. R. Soc. Interface 1(1), 79–90 (2004).

[48] T. C. Bakker Schut, R. Wolthuis, P. J. Caspers, G. J. Puppels, "Real-time tissue characterization on the basis of in vivo Raman spectra," J. Raman Spectrosc. 33(7), 580–585 (2002).

[49] P. Crow, B. Barrass, C. Kendall, M. Hart-Prieto, M. Wright, R. Persad, N. Stone, "The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines," Br. J. Cancer 92(12), 2166–2170 (2005).

[50] T. J. Harvey, E. Gazi, A. Henderson, R. D. Snook, N. W. Clarke, M. Brown, P. Gardner, "Factors influencing the discrimination and classification of prostate cancer cell lines by FTIR microspectroscopy," Analyst 134(6), 1083–1091 (2009).

[51] E. Vargis, Y. W. Tang, D. Khabele, A. Mahadevan- Jansen, "Near-infrared Raman microspectroscopy detects high-risk human papillomaviruses," Transl. Oncol. 5(3), 172–179 (2012).

[52] K. M. Ostrowska, A. Malkin, A. Meade, J. O'Leary, C. Martin, C. Spillane, H. J. Byrne, F. M. Lyng, "Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy," Analyst 135(12), 3087–3093 (2010). Investigating the effects of Pentoxifylline on human breast cancer cells 1550004-11